Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Alterity Therapeutics Ltd. ( (AU:ATH) ).
Alterity Therapeutics Limited has reported a change in the voting interests held by The Bank of New York Mellon Corporation (BNYMC) and its affiliated entities. The BNYMC Group’s voting power in Alterity Therapeutics has increased from 39.55% to 41.28%, reflecting a shift in their stake within the company. This change signifies a notable increase in influence for the BNYMC Group within Alterity Therapeutics, potentially impacting future company decisions and stakeholder dynamics.
More about Alterity Therapeutics Ltd.
YTD Price Performance: 0%
Average Trading Volume: 100
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $46.3M
For a thorough assessment of ATH stock, go to TipRanks’ Stock Analysis page.
